Head to head

Stellar M22 vs Venus Versa Pro (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: Catalog new-price ranges: Stellar M22, $90k–$130k; Venus Versa Pro, $100k–$130k. Check the source notes and request current quotes.
Practice fit: Both are listed under IPL multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

IPL multi-app platform

View full device profile →

Device B

IPL multi-app platform

View full device profile →

Price comparison

Price comparison: Lumenis Stellar M22 vs Venus Versa Pro
Attribute	Lumenis Stellar M22	Venus Versa Pro
New price range	$90k–$130kSource not documented	$100k–$130kSource not documented
Used asking range	$55k–$85kSource not documented	Not published
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Lumenis Stellar M22: $90k–$130kSource not documented
Venus Versa Pro: $100k–$130kSource not documented

Used asking range

Lumenis Stellar M22: $55k–$85kSource not documented
Venus Versa Pro: Not published

Payback calculator

Lumenis Stellar M22: View ROI calculator
Venus Versa Pro: View ROI calculator

Next step

Lumenis Stellar M22

Venus Versa Pro

Consumable economics

Consumable economics: Lumenis Stellar M22 vs Venus Versa Pro
Attribute	Lumenis Stellar M22	Venus Versa Pro
Consumable cost / lock-in	Supply pricing is not documented with a dated source yet. Request an itemized supply quote.	—
Service cost	Not published	Not published

Consumable cost / lock-in

Lumenis Stellar M22: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Venus Versa Pro: —

Service cost

Lumenis Stellar M22: Not published
Venus Versa Pro: Not published

FDA clearance

FDA clearance: Lumenis Stellar M22 vs Venus Versa Pro
Attribute	Lumenis Stellar M22	Venus Versa Pro
FDA status & indication	FDA ClearedK193500, K250809, De Novo: DEN200028 Read FDA indication wording “The subject Stellar M22 has connection capability with the following available treatment handpieces, for multi-application treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows:  The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200 nm (with 9 different filters) is indicated for: o Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, and ephelides (freckles) o Cutaneous lesions, including warts, scars and striae o Benign cutaneous vascular lesions, including port wine stains, hemoangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations o Removal of unwanted hair and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o Mild to moderate inflammatory Acne (Acne vulgaris)  The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: o The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1-4.0 mm. diameter) of the leg o The removal of unwanted hair and to effect table long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o The non-ablative treatment of facial wrinkles  ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: o Use in dermatological procedures requiring fractional skin resurfacing and0684 coagulation of soft tissue  The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064 nm is indicated for: o Removal of dark tattoos o Treatment of pigmented lesions *Note Permanent hair reduction is defined as long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after completion of treatment regime.”	FDA ClearedK232192 Read FDA indication wording “The Venus Versa PRO System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva MD applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”

FDA status & indication

Lumenis Stellar M22: FDA ClearedK193500, K250809, De Novo: DEN200028
Read FDA indication wording
“The subject Stellar M22 has connection capability with the following available treatment handpieces, for multi-application treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows:  The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200 nm (with 9 different filters) is indicated for: o Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, and ephelides (freckles) o Cutaneous lesions, including warts, scars and striae o Benign cutaneous vascular lesions, including port wine stains, hemoangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations o Removal of unwanted hair and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o Mild to moderate inflammatory Acne (Acne vulgaris)  The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: o The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1-4.0 mm. diameter) of the leg o The removal of unwanted hair and to effect table long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o The non-ablative treatment of facial wrinkles  ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: o Use in dermatological procedures requiring fractional skin resurfacing and0684 coagulation of soft tissue  The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064 nm is indicated for: o Removal of dark tattoos o Treatment of pigmented lesions *Note Permanent hair reduction is defined as long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after completion of treatment regime.”
Venus Versa Pro: FDA ClearedK232192
Read FDA indication wording
“The Venus Versa PRO System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva MD applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”

Which chains run each

Which chains run each: Lumenis Stellar M22 vs Venus Versa Pro
Attribute	Lumenis Stellar M22	Venus Versa Pro
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Lumenis Stellar M22: 0 recorded pairings
Venus Versa Pro: 0 recorded pairings

Chains using it

Lumenis Stellar M22: —
Venus Versa Pro: —

Approved reviews

Lumenis Stellar M22: 0
Venus Versa Pro: 0

Specs and platform

Specs and platform: Lumenis Stellar M22 vs Venus Versa Pro
Attribute	Lumenis Stellar M22	Venus Versa Pro
Manufacturer	Lumenis	Venus Concept
Built by (OEM)	Lumenis Be Ltd.	Venus Concept Inc.
Category	IPL multi-app platform	IPL multi-app platform
Technology	Updated M22, larger IPL spot (IPL)	Updated IPL/HR multi-app (IPL)
Launch year	2019	2023
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Lumenis Stellar M22: Lumenis
Venus Versa Pro: Venus Concept

Built by (OEM)

Lumenis Stellar M22: Lumenis Be Ltd.
Venus Versa Pro: Venus Concept Inc.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

InMode Envision

IPL multi-app platform

New: —

InMode Optimas

IPL multi-app platform

New: $90k–$130k

SharpLight OmniMax S4

IPL multi-app platform

New: $60k–$90k

Viora V30

IPL multi-app platform

New: $50k–$80k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.